Human papilloma virus (HPV) vaccine

Christin Kilcrease, Pharm.D., Janessa M. Smith, PharmD, BCPS
Human papilloma virus (HPV) vaccine is a topic covered in the Johns Hopkins ABX Guide.

To view the entire topic, please or .

Official website of the Johns Hopkins Antibiotic (ABX), HIV, Diabetes, and Psychiatry Guides, powered by Unbound Medicine. Johns Hopkins Guide App for iOS, iPhone, iPad, and Android included. Explore these free sample topics:

-- The first section of this topic is shown below --

VACCINE TYPE

  • Historically, three types of recombinant, subunit particle vaccines have been used, only 9-valent available in U.S. (2017):
    • 9-valent (types 6, 11, 16, 18, 31, 33, 45, 52, 58)
    • Quadrivalent (types 6, 11, 16, 18)
    • Bivalent (types 16, 18)
  • Vaccines contain virus-like particles (VLP) that do not contain genetic material, so they are non-infectious.

-- To view the remaining sections of this topic, please or --

VACCINE TYPE

  • Historically, three types of recombinant, subunit particle vaccines have been used, only 9-valent available in U.S. (2017):
    • 9-valent (types 6, 11, 16, 18, 31, 33, 45, 52, 58)
    • Quadrivalent (types 6, 11, 16, 18)
    • Bivalent (types 16, 18)
  • Vaccines contain virus-like particles (VLP) that do not contain genetic material, so they are non-infectious.

There's more to see -- the rest of this entry is available only to subscribers.

Last updated: June 5, 2020